An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
This study is enrolling participants by invitation only.
Sponsor:
Novo Nordisk
Information provided by (Responsible Party):
Novo Nordisk
ClinicalTrials.gov Identifier:
NCT01511393
First received: November 30, 2011
Last updated: May 1, 2013
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | December 2025 |
| Estimated Primary Completion Date: | December 2025 (Final data collection date for primary outcome measure) |